Does LORLATINIB Cause Pleural effusion? 138 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 138 reports of Pleural effusion have been filed in association with LORLATINIB (Lorbrena). This represents 2.5% of all adverse event reports for LORLATINIB.
138
Reports of Pleural effusion with LORLATINIB
2.5%
of all LORLATINIB reports
31
Deaths
65
Hospitalizations
How Dangerous Is Pleural effusion From LORLATINIB?
Of the 138 reports, 31 (22.5%) resulted in death, 65 (47.1%) required hospitalization, and 7 (5.1%) were considered life-threatening.
Is Pleural effusion Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LORLATINIB. However, 138 reports have been filed with the FAERS database.
What Other Side Effects Does LORLATINIB Cause?
Death (1,050)
Neoplasm progression (633)
Off label use (394)
Weight increased (306)
Hallucination (290)
Blood cholesterol increased (281)
Dyspnoea (223)
Oedema peripheral (198)
Oedema (195)
Fatigue (188)
What Other Drugs Cause Pleural effusion?
DASATINIB (2,424)
METHOTREXATE (1,310)
CYCLOPHOSPHAMIDE (1,239)
IBRUTINIB (1,205)
RITUXIMAB (1,168)
PREDNISONE (1,144)
NIVOLUMAB (1,061)
ADALIMUMAB (1,036)
DEXAMETHASONE (879)
PACLITAXEL (862)
Which LORLATINIB Alternatives Have Lower Pleural effusion Risk?
LORLATINIB vs LORMETAZEPAM
LORLATINIB vs LORNOXICAM
LORLATINIB vs LOSARTAN
LORLATINIB vs LOSARTAN\LOSARTAN
LORLATINIB vs LOTEPREDNOL ETABONATE